Retreatment of chronic hepatitis C patients resistant to previous interferon/ribavirin combination therapy with interferon alpha, ribavirin and amantadin: a triple therapy pilot study (CROSBI ID 619495)
Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Vucelić, Boris ; Hrstić, Irena ; Ostojić, Rajko ; Ščukanec-Špoljar, Mira ; Grahovac, Blaženka ; Restek-Samaržija, Nada
hrvatski
Retreatment of chronic hepatitis C patients resistant to previous interferon/ribavirin combination therapy with interferon alpha, ribavirin and amantadin: a triple therapy pilot study
Retreatment of chronic hepatitis C patients resistant to previous interferon/ribavirin combination therapy with interferon alpha, ribavirin and amantadin: a triple therapy pilot study
chronic hepatitis C
nije evidentirano
engleski
Retreatment of chronic hepatitis C patients resistant to previous interferon/ribavirin combination therapy with interferon alpha, ribavirin and amantadin: a triple therapy pilot study
nije evidentirano
chronic hepatitis C
nije evidentirano
Podaci o prilogu
111-111.
2001.
nije evidentirano
objavljeno
Podaci o matičnoj publikaciji
Acta medica Croatica
1330-0164
Podaci o skupu
Konferencija
poster
01.01.2001-01.01.2001
Konferencija
